UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): January 5, 2009
CDEX INC.
(Exact name of registrant as specified in its charter)
Nevada 000-49845 52-2336836
------ --------- ----------
(State or other jurisdiction of (Commission (I.R.S. Employer
incorporation or organization) File Number) Identification No.)
4555 South Palo Verde, Suite 123
Tucson, Arizona 85714
--------------- -----
(Address of principal executive offices) (Zip Code)
(520) 745-5172
--------------
(Registrant's telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[_] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events
On January 5, 2009, CDEX, Inc. announced the introduction to the North American
Markets of ValiMed(TM) Model CCT at the annual conference of the American
Society of Health-System Pharmacists (ASHP) held recently in Orlando, Florida.
CDEX also announced the promotion of Greg Firmbach to Vice President of the
Medication Safety Division for North America. Mr. Firmbach joins CDEX with more
than 25 years of experience in the healthcare arena.
A copy of a press release issued on January 5, 2009 announcing the introduction
of the CCT to the North American markets and the promotion of Mr. Firmbach is
attached to this Current Report as Exhibit 99.1 and is incorporated herein by
reference.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
Exhibit
- -------
Number Title of Document
- ------ -----------------
99.1 Press Release, dated January 5, 2009
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CDEX INC.
Date: January 8, 2009 By: /s/ Malcolm H. Philips, Jr.
---------------------------
Malcolm H. Philips, Jr., President